IndraLab

Statements


1 | 8

reach
"Celecoxib Suppresses NF-kappaB p65 (RelA) and TNFalpha Expression Signaling in Glioblastoma."

reach
"Celecoxib Suppresses NF-kappaB p65 (RelA) and TNFalpha Expression Signaling in Glioblastoma."

reach
"Here, we hypothesized that celecoxib-mediated antineoplastic responses in GBM may prevent NF-κB p65 (RelA) activation due to its various roles in GBM."

reach
"Here, we hypothesized that celecoxib-mediated antineoplastic responses in GBM may prevent NF-κB p65 (RelA) activation due to its various roles in GBM."

reach
"Celecoxib just slightly reduced NF-kappaB p65 mRNA in the T2DM-NASH-Cele group (XREF_FIG)."

reach
"The results from the NF-kappaB activity assay suggested that SIRT1 activation led to decreased nuclear translocation of NF-kappaB (p65) in the liver and spleen tissues of mice treated with imipenem or celecoxib alone and in combination."

reach
"Celecoxib can inhibit NF-κB p65 activation, combat the pro-inflammatory milieu, and improve therapeutic outcomes."

reach
"In our study, we demonstrated that Celecoxib inhibited the NF-κB expression — p65 and p52 in a dose dependent manner in MDA-MB-231 and SKBR3 cell lines respectively."